Lone Star Funds to Acquire the Capsules & Health Ingredients Division of Lonza Group AG

Lonza to offload CHI biz to Lone Star in $3bn transaction

The move marks the culmination of Lonza’s transformation and positions the company to focus exclusively on its CDMO operations.

Lone Star strikes $3bn deal for Lonza capsules and health ingredients unit

Private equity firm Lone Star Funds has agreed to acquire the capsules and health ingredients division of Swiss life sciences group Lonza in a transaction valuing the business at CHF2.3bn (around $3bn), according to a report by Reuters. The deal will see Lone Star take control of the unit while Lonza retains a 40% minority interest. The company will receive approximately CHF1.7bn in upfront proceeds, with total undiscounted proceeds from the tra…

Lone Star Funds to Acquire the Capsules & Health Ingredients Division of Lonza Group AG

DALLAS & NEW YORK & LONDON & TOKYO–(BUSINESS WIRE)–Lone Star Funds today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comp…